BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17601318)

  • 1. [Number needed to treat (NNT)--sound or stupid as a basis for decision?].
    Svangren P
    Lakartidningen; 2007 May 30-Jun 3; 104(22):1690-4. PubMed ID: 17601318
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpretation of absolute measures of disease risk in comparative research.
    Replogle WH; Johnson WD
    Fam Med; 2007 Jun; 39(6):432-5. PubMed ID: 17549653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Number needed to treat (NNT)-- misleading, misunderstood, misused?].
    Wisløff T; Halvorsen PA; Kristiansen IS
    Tidsskr Nor Laegeforen; 2004 Aug; 124(15):1926-9. PubMed ID: 15306861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number remaining at risk: an adjunct to the number needed to treat.
    Massel D; Cruickshank MK
    Can J Cardiol; 2002 Mar; 18(3):254-8. PubMed ID: 11907613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.
    Hutton JL
    Br J Haematol; 2009 Jun; 146(1):27-30. PubMed ID: 19438480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainty in the minimum event risk to justify treatment was evaluated.
    Walter SD; Sinclair JC
    J Clin Epidemiol; 2009 Aug; 62(8):816-24. PubMed ID: 19216053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compelling or irrelevant? Using number needed to treat can help decide.
    Citrome L
    Acta Psychiatr Scand; 2008 Jun; 117(6):412-9. PubMed ID: 18479317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the way results are presented on research interpretation and medical decision making: the PRIMER collaboration randomized studies.
    Shakespeare TP; Gebski V; Tang J; Lim K; Lu JJ; Zhang X; Jiang G
    Med Decis Making; 2008; 28(1):127-37. PubMed ID: 18083993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [One per cent medicine--a source of overtreatment].
    Følling I
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):334-6. PubMed ID: 18264162
    [No Abstract]   [Full Text] [Related]  

  • 11. [How should risk be reported?].
    Nielsen GL; Tage-Jensen U; Nielsen TT; Sørensen HT
    Ugeskr Laeger; 2005 Jan; 167(4):375-9. PubMed ID: 15719559
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain?
    Edelsberg J; Oster G
    Eur J Pain; 2009 Jan; 13(1):11-6. PubMed ID: 18456524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the use of patient data to improve outcomes for patients: narcotics for chronic noncancer pain.
    Busse JW; Guyatt GH
    Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):171-9. PubMed ID: 19402805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of antibiotic prophylaxis in third molar surgery: a meta-analysis of randomized controlled clinical trials.
    Ren YF; Malmstrom HS
    J Oral Maxillofac Surg; 2007 Oct; 65(10):1909-21. PubMed ID: 17884515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number needed to treat needs an associated odds estimation.
    Aino H; Yanagisawa S; Kamae I
    J Public Health (Oxf); 2004 Mar; 26(1):84-7. PubMed ID: 15044581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the syntax study relevant for decision-taking in cardiology?].
    Irarrázaval Ll MJ
    Rev Med Chil; 2009 Nov; 137(11):1535-7. PubMed ID: 20098819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of risk number in chronic diseases. Number needed to cheat?].
    Kristiansen IS; Thelle DS
    Tidsskr Nor Laegeforen; 1998 Aug; 118(19):2938. PubMed ID: 9748829
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
    Gravel J; Opatrny L; Shapiro S
    Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.